Contact Lens Wearers With Dry Eye Syndrome Clinical Trial
Official title:
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
NCT number | NCT00335114 |
Other study ID # | F051025017 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2005 |
Est. completion date | April 2006 |
Verified date | May 2023 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cyclosporine Ophthalmic Emulsion is currently used in the treatment of dry eye syndrome. Contact lens wearers frequently suffer from dry eye syndrome. The purpose of this study is to evaluate cyclosporine ophthalmic emulsion verses re-wetting drops in the relief of dry eye symptoms in contact lens wearers
Status | Completed |
Enrollment | 40 |
Est. completion date | April 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - contact lens wearer - clinical diagnosis of dry eye syndrome Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
United States | UAB Ophthalmology Services Foundation | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ocular exams and questionnaires at baseline and at 3 months will determine | |||
Primary | the effect of cyclosporine on dry eye syndrome. | |||
Secondary | Increased contact lens wearing time due to a decrease in severity | |||
Secondary | of dry eye symptoms |